Gerald W. McLaughlin, Chief Executive Officer at Neos Therapeutics, Inc. (NEOS), bought 7,403 shares at $2.04 ($15K) on 2018-12-04, disclosed to the SEC on 2018-12-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.